Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 3Suspended 2Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Carcinoma 1

Interventions

Specimen Handling 76Bevacizumab 66Drug Therapy 64Cisplatin 64Carboplatin 63Magnetic Resonance Spectroscopy 59Radiotherapy 57pembrolizumab 54Gemcitabine 54Cyclophosphamide 54Capecitabine 51Oxaliplatin 50toripalimab 44Paclitaxel 41tislelizumab 40Standard of Care 39fludarabine 36Fluorouracil 35Injections 34Biopsy 34venetoclax 33Blood Specimen Collection 31Immune Checkpoint Inhibitors 30anlotinib 29Surgical Procedures, Operative 28Nivolumab 28Irinotecan 27Docetaxel 27Dexamethasone 27Leucovorin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × (225)Ac-DOTA-c(RGDyK) × 1 year × Clear all
NCT07441681 2026-05-04

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NRG Oncology

Phase 3 Not yet recruiting
454 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡